APO Research
Talk to an analyst

APO RESEARCH · REPORT

Companion Animal Specialty Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Companion Animal Specialty Drugs Industry Growth and Trends Forecast to 2032

20 December 202590 pages

Choose your research edition.

Industry ResearchCompanion Animal Specialty Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Companion Animal Specialty Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Companion Animal Specialty Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Companion Animal Specialty Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Companion Animal Specialty Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Companion Animal Specialty Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Companion Animal Specialty Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Companion Animal Specialty Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Companion Animal Specialty Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Companion Animal Specialty Drugs include Zoetis, Bayer, The J.M Smucker Company, Merial, Mars, Henry Schein, Elanco, Beaphar and Aratana therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Companion Animal Specialty Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Companion Animal Specialty Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Companion Animal Specialty Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Companion Animal Specialty Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Companion Animal Specialty Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Companion Animal Specialty Drugs Market by Company

Zoetis

Bayer

The J.M Smucker Company

Merial

Mars

Henry Schein

Elanco

Beaphar

Aratana therapeutics

Companion Animal Specialty Drugs Segment by Type

Antibiotics

Parasiticides

Feed Additives

Vaccines

Other

Companion Animal Specialty Drugs Segment by Application

Pharmacy Stores

Veterinary Hospitals

Pet Care Clinics

Companion Animal Specialty Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Specialty Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Specialty Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Specialty Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Companion Animal Specialty Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Companion Animal Specialty Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antibiotics Table 2. Major Company of Parasiticides Table 3. Major Company of Feed Additives Table 4. Major Company of Vaccines Table 5. Major Company of Other Table 6. Global Companion Animal Specialty Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Companion Animal Specialty Drugs Sales by Type (2021-2026) & (K Units) Table 8. Global Companion Animal Specialty Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Companion Animal Specialty Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Companion Animal Specialty Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Companion Animal Specialty Drugs Price by Type (2021-2026) & (US$/Unit) Table 12. Global Companion Animal Specialty Drugs Sales by Type (2027-2032) & (K Units) Table 13. Global Companion Animal Specialty Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Companion Animal Specialty Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Companion Animal Specialty Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Companion Animal Specialty Drugs Price by Type (2027-2032) & (US$/Unit) Table 17. North America Companion Animal Specialty Drugs Sales by Type (2021-2026) & (K Units) Table 18. North America Companion Animal Specialty Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Companion Animal Specialty Drugs Sales by Type (2021-2026) & (K Units) Table 20. Europe Companion Animal Specialty Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Companion Animal Specialty Drugs Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Companion Animal Specialty Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Companion Animal Specialty Drugs Sales by Type (2021-2026) & (K Units) Table 24. Latin America Companion Animal Specialty Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Companion Animal Specialty Drugs Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Companion Animal Specialty Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Companion Animal Specialty Drugs Industry Trends Table 28. Companion Animal Specialty Drugs Industry Drivers Table 29. Companion Animal Specialty Drugs Industry Opportunities and Challenges Table 30. Companion Animal Specialty Drugs Industry Restraints Table 31. Global Companion Animal Specialty Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Companion Animal Specialty Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Companion Animal Specialty Drugs Sales by Company (2021-2026) & (K Units) Table 34. Global Companion Animal Specialty Drugs Sales Share by Company (2021-2026) Table 35. Global Companion Animal Specialty Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Companion Animal Specialty Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Companion Animal Specialty Drugs Major Company Production Sites and Headquarters Table 38. Global Companion Animal Specialty Drugs Company, Product Type & Application Table 39. Global Companion Animal Specialty Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Companion Animal Specialty Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Companion Animal Specialty Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Companion Animal Specialty Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Companion Animal Specialty Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Companion Animal Specialty Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Companion Animal Specialty Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Companion Animal Specialty Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Companion Animal Specialty Drugs Sales by Region (2027-2032) & (K Units) Table 49. Global Companion Animal Specialty Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Companion Animal Specialty Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Companion Animal Specialty Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Companion Animal Specialty Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Companion Animal Specialty Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Companion Animal Specialty Drugs Sales by Application (2021-2026) & (K Units) Table 55. Global Companion Animal Specialty Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Companion Animal Specialty Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Companion Animal Specialty Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Companion Animal Specialty Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global Companion Animal Specialty Drugs Sales by Application (2027-2032) & (K Units) Table 60. Global Companion Animal Specialty Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Companion Animal Specialty Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Companion Animal Specialty Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Companion Animal Specialty Drugs Price by Application (2027-2032) & (US$/Unit) Table 64. North America Companion Animal Specialty Drugs Sales by Application (2021-2026) & (K Units) Table 65. North America Companion Animal Specialty Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Companion Animal Specialty Drugs Sales by Application (2021-2026) & (K Units) Table 67. Europe Companion Animal Specialty Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Companion Animal Specialty Drugs Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Companion Animal Specialty Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Companion Animal Specialty Drugs Sales by Application (2021-2026) & (K Units) Table 71. Latin America Companion Animal Specialty Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Companion Animal Specialty Drugs Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Companion Animal Specialty Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Zoetis Company Information Table 75. Zoetis Business Overview Table 76. Zoetis Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Zoetis Companion Animal Specialty Drugs Product Portfolio Table 78. Zoetis Recent Development Table 79. Bayer Company Information Table 80. Bayer Business Overview Table 81. Bayer Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Bayer Companion Animal Specialty Drugs Product Portfolio Table 83. Bayer Recent Development Table 84. The J.M Smucker Company Company Information Table 85. The J.M Smucker Company Business Overview Table 86. The J.M Smucker Company Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. The J.M Smucker Company Companion Animal Specialty Drugs Product Portfolio Table 88. The J.M Smucker Company Recent Development Table 89. Merial Company Information Table 90. Merial Business Overview Table 91. Merial Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Merial Companion Animal Specialty Drugs Product Portfolio Table 93. Merial Recent Development Table 94. Mars Company Information Table 95. Mars Business Overview Table 96. Mars Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Mars Companion Animal Specialty Drugs Product Portfolio Table 98. Mars Recent Development Table 99. Henry Schein Company Information Table 100. Henry Schein Business Overview Table 101. Henry Schein Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Henry Schein Companion Animal Specialty Drugs Product Portfolio Table 103. Henry Schein Recent Development Table 104. Elanco Company Information Table 105. Elanco Business Overview Table 106. Elanco Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Elanco Companion Animal Specialty Drugs Product Portfolio Table 108. Elanco Recent Development Table 109. Beaphar Company Information Table 110. Beaphar Business Overview Table 111. Beaphar Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Beaphar Companion Animal Specialty Drugs Product Portfolio Table 113. Beaphar Recent Development Table 114. Aratana therapeutics Company Information Table 115. Aratana therapeutics Business Overview Table 116. Aratana therapeutics Companion Animal Specialty Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Aratana therapeutics Companion Animal Specialty Drugs Product Portfolio Table 118. Aratana therapeutics Recent Development Table 119. North America Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. North America Companion Animal Specialty Drugs Sales by Country (2021-2026) & (K Units) Table 121. North America Companion Animal Specialty Drugs Sales Market Share by Country (2021-2026) Table 122. North America Companion Animal Specialty Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 123. North America Companion Animal Specialty Drugs Sales Market Share Forecast by Country (2027-2032) Table 124. North America Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Companion Animal Specialty Drugs Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Companion Animal Specialty Drugs Market Share by Country (2021-2026) Table 127. North America Companion Animal Specialty Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Companion Animal Specialty Drugs Market Share Forecast by Country (2027-2032) Table 129. Europe Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Europe Companion Animal Specialty Drugs Sales by Country (2021-2026) & (K Units) Table 131. Europe Companion Animal Specialty Drugs Sales Market Share by Country (2021-2026) Table 132. Europe Companion Animal Specialty Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 133. Europe Companion Animal Specialty Drugs Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Companion Animal Specialty Drugs Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Companion Animal Specialty Drugs Market Share by Country (2021-2026) Table 137. Europe Companion Animal Specialty Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Companion Animal Specialty Drugs Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Companion Animal Specialty Drugs Sales by Country (2021-2026) & (K Units) Table 141. Asia-Pacific Companion Animal Specialty Drugs Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Companion Animal Specialty Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 143. Asia-Pacific Companion Animal Specialty Drugs Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Companion Animal Specialty Drugs Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Companion Animal Specialty Drugs Market Share by Country (2021-2026) Table 147. Asia-Pacific Companion Animal Specialty Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Companion Animal Specialty Drugs Market Share Forecast by Country (2027-2032) Table 149. Latin America Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Latin America Companion Animal Specialty Drugs Sales by Country (2021-2026) & (K Units) Table 151. Latin America Companion Animal Specialty Drugs Sales Market Share by Country (2021-2026) Table 152. Latin America Companion Animal Specialty Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 153. Latin America Companion Animal Specialty Drugs Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Companion Animal Specialty Drugs Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Companion Animal Specialty Drugs Market Share by Country (2021-2026) Table 157. Latin America Companion Animal Specialty Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Companion Animal Specialty Drugs Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Companion Animal Specialty Drugs Sales by Country (2021-2026) & (K Units) Table 161. Middle East and Africa Companion Animal Specialty Drugs Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Companion Animal Specialty Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 163. Middle East and Africa Companion Animal Specialty Drugs Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Companion Animal Specialty Drugs Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Companion Animal Specialty Drugs Market Share by Country (2021-2026) Table 167. Middle East and Africa Companion Animal Specialty Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Companion Animal Specialty Drugs Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Companion Animal Specialty Drugs Distributors List Table 172. Companion Animal Specialty Drugs Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Companion Animal Specialty Drugs Image Figure 2. Global Companion Animal Specialty Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Companion Animal Specialty Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Companion Animal Specialty Drugs Sales (2021-2032) & (K Units) Figure 5. Antibiotics Image Figure 6. Global Antibiotics Sales YoY Growth (2021-2032) & (K Units) Figure 7. Parasiticides Image Figure 8. Global Parasiticides Sales YoY Growth (2021-2032) & (K Units) Figure 9. Feed Additives Image Figure 10. Global Feed Additives Sales YoY Growth (2021-2032) & (K Units) Figure 11. Vaccines Image Figure 12. Global Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 13. Other Image Figure 14. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Companion Animal Specialty Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Companion Animal Specialty Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Companion Animal Specialty Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Companion Animal Specialty Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Companion Animal Specialty Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Companion Animal Specialty Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Companion Animal Specialty Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Companion Animal Specialty Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Companion Animal Specialty Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Companion Animal Specialty Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Companion Animal Specialty Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Companion Animal Specialty Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Companion Animal Specialty Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Pharmacy Stores Image Figure 30. Global Pharmacy Stores Sales YoY Growth (2021-2032) & (K Units) Figure 31. Veterinary Hospitals Image Figure 32. Global Veterinary Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 33. Pet Care Clinics Image Figure 34. Global Pet Care Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Companion Animal Specialty Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Companion Animal Specialty Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Companion Animal Specialty Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Companion Animal Specialty Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Companion Animal Specialty Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Companion Animal Specialty Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Companion Animal Specialty Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Companion Animal Specialty Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Companion Animal Specialty Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Companion Animal Specialty Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Companion Animal Specialty Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Companion Animal Specialty Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Companion Animal Specialty Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Companion Animal Specialty Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Companion Animal Specialty Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Companion Animal Specialty Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Companion Animal Specialty Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Companion Animal Specialty Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Companion Animal Specialty Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Companion Animal Specialty Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Companion Animal Specialty Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Companion Animal Specialty Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Companion Animal Specialty Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Companion Animal Specialty Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Companion Animal Specialty Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Companion Animal Specialty Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Companion Animal Specialty Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Companion Animal Specialty Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Companion Animal Specialty Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Companion Animal Specialty Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Companion Animal Specialty Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Companion Animal Specialty Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Companion Animal Specialty Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Companion Animal Specialty Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Parasiticides
  • Feed Additives
  • Vaccines
  • Other
Applications
  • Pharmacy Stores
  • Veterinary Hospitals
  • Pet Care Clinics
Companies covered
  • Zoetis
  • Bayer
  • The J.M Smucker Company
  • Merial
  • Mars
  • Henry Schein
  • Elanco
  • Beaphar
  • Aratana therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Companion Animal Specialty Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Companion Animal Specialty Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Companion Animal Specialty Drugs Market by Type
  6. 1.3.1 Antibiotics
  7. 1.3.2 Parasiticides
  8. 1.3.3 Feed Additives
  9. 1.3.4 Vaccines
  10. 1.3.5 Other
  11. 1.4 Global Companion Animal Specialty Drugs Market Size by Type
  12. 1.4.1 Global Companion Animal Specialty Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Companion Animal Specialty Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Companion Animal Specialty Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Companion Animal Specialty Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Companion Animal Specialty Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Companion Animal Specialty Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Companion Animal Specialty Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Companion Animal Specialty Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Companion Animal Specialty Drugs Industry Trends
  2. 2.2 Companion Animal Specialty Drugs Industry Drivers
  3. 2.3 Companion Animal Specialty Drugs Industry Opportunities and Challenges
  4. 2.4 Companion Animal Specialty Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Companion Animal Specialty Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Companion Animal Specialty Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Companion Animal Specialty Drugs Price (2021-2026)
  4. 3.4 Global Companion Animal Specialty Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Companion Animal Specialty Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Companion Animal Specialty Drugs Company, Product Type & Application
  7. 3.7 Global Companion Animal Specialty Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Companion Animal Specialty Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Companion Animal Specialty Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Companion Animal Specialty Drugs Tier 1, Tier 2, and Tier 3
4 Companion Animal Specialty Drugs Regional Status and Outlook
  1. 4.1 Global Companion Animal Specialty Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Companion Animal Specialty Drugs Historic Market Size by Region
  3. 4.2.1 Global Companion Animal Specialty Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Companion Animal Specialty Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Companion Animal Specialty Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Companion Animal Specialty Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Companion Animal Specialty Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Companion Animal Specialty Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Companion Animal Specialty Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Companion Animal Specialty Drugs by Application
  1. 5.1 Companion Animal Specialty Drugs Market by Application
  2. 5.1.1 Pharmacy Stores
  3. 5.1.2 Veterinary Hospitals
  4. 5.1.3 Pet Care Clinics
  5. 5.2 Global Companion Animal Specialty Drugs Market Size by Application
  6. 5.2.1 Global Companion Animal Specialty Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Companion Animal Specialty Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Companion Animal Specialty Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Companion Animal Specialty Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Companion Animal Specialty Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Companion Animal Specialty Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Companion Animal Specialty Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Companion Animal Specialty Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis
  2. 6.1.1 Zoetis Company Information
  3. 6.1.2 Zoetis Business Overview
  4. 6.1.3 Zoetis Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Companion Animal Specialty Drugs Product Portfolio
  6. 6.1.5 Zoetis Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Companion Animal Specialty Drugs Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 The J.M Smucker Company
  14. 6.3.1 The J.M Smucker Company Company Information
  15. 6.3.2 The J.M Smucker Company Business Overview
  16. 6.3.3 The J.M Smucker Company Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 The J.M Smucker Company Companion Animal Specialty Drugs Product Portfolio
  18. 6.3.5 The J.M Smucker Company Recent Developments
  19. 6.4 Merial
  20. 6.4.1 Merial Company Information
  21. 6.4.2 Merial Business Overview
  22. 6.4.3 Merial Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merial Companion Animal Specialty Drugs Product Portfolio
  24. 6.4.5 Merial Recent Developments
  25. 6.5 Mars
  26. 6.5.1 Mars Company Information
  27. 6.5.2 Mars Business Overview
  28. 6.5.3 Mars Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mars Companion Animal Specialty Drugs Product Portfolio
  30. 6.5.5 Mars Recent Developments
  31. 6.6 Henry Schein
  32. 6.6.1 Henry Schein Company Information
  33. 6.6.2 Henry Schein Business Overview
  34. 6.6.3 Henry Schein Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Henry Schein Companion Animal Specialty Drugs Product Portfolio
  36. 6.6.5 Henry Schein Recent Developments
  37. 6.7 Elanco
  38. 6.7.1 Elanco Company Information
  39. 6.7.2 Elanco Business Overview
  40. 6.7.3 Elanco Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Elanco Companion Animal Specialty Drugs Product Portfolio
  42. 6.7.5 Elanco Recent Developments
  43. 6.8 Beaphar
  44. 6.8.1 Beaphar Company Information
  45. 6.8.2 Beaphar Business Overview
  46. 6.8.3 Beaphar Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Beaphar Companion Animal Specialty Drugs Product Portfolio
  48. 6.8.5 Beaphar Recent Developments
  49. 6.9 Aratana therapeutics
  50. 6.9.1 Aratana therapeutics Company Information
  51. 6.9.2 Aratana therapeutics Business Overview
  52. 6.9.3 Aratana therapeutics Companion Animal Specialty Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Aratana therapeutics Companion Animal Specialty Drugs Product Portfolio
  54. 6.9.5 Aratana therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Companion Animal Specialty Drugs Sales by Country
  2. 7.1.1 North America Companion Animal Specialty Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Companion Animal Specialty Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Companion Animal Specialty Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Companion Animal Specialty Drugs Market Size by Country
  6. 7.2.1 North America Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Companion Animal Specialty Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Companion Animal Specialty Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Companion Animal Specialty Drugs Sales by Country
  2. 8.1.1 Europe Companion Animal Specialty Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Companion Animal Specialty Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Companion Animal Specialty Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Companion Animal Specialty Drugs Market Size by Country
  6. 8.2.1 Europe Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Companion Animal Specialty Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Companion Animal Specialty Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Companion Animal Specialty Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Companion Animal Specialty Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Companion Animal Specialty Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Companion Animal Specialty Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Companion Animal Specialty Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Companion Animal Specialty Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Companion Animal Specialty Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Companion Animal Specialty Drugs Sales by Country
  2. 10.1.1 South America Companion Animal Specialty Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Companion Animal Specialty Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Companion Animal Specialty Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Companion Animal Specialty Drugs Market Size by Country
  6. 10.2.1 South America Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Companion Animal Specialty Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Companion Animal Specialty Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Companion Animal Specialty Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Companion Animal Specialty Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Companion Animal Specialty Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Companion Animal Specialty Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Companion Animal Specialty Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Companion Animal Specialty Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Companion Animal Specialty Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Companion Animal Specialty Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Companion Animal Specialty Drugs Value Chain Analysis
  2. 12.1.1 Companion Animal Specialty Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Companion Animal Specialty Drugs Production Mode & Process
  7. 12.2 Companion Animal Specialty Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Companion Animal Specialty Drugs Distributors
  10. 12.2.3 Companion Animal Specialty Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst